# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-022778
Filing Date
2025-02-19
Accepted
2025-02-19 09:00:23
Documents
67
Period of Report
2024-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | onvo-20241231.htm iXBRL | 10-Q | 2556640
2 | EX-31.1 | onvo-ex31_1.htm | EX-31.1 | 13474
3 | EX-31.2 | onvo-ex31_2.htm | EX-31.2 | 13442
4 | EX-32.1 | onvo-ex32_1.htm | EX-32.1 | 11215
| Complete submission text file | 0000950170-25-022778.txt |  | 9082186

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | onvo-20241231.xsd | EX-101.SCH | 1191843
70 | EXTRACTED XBRL INSTANCE DOCUMENT | onvo-20241231_htm.xml | XML | 1539051

Mailing Address 11555 SORRENTO VALLEY ROAD SUITE 100 SAN DIEGO CA 92121
Business Address 11555 SORRENTO VALLEY ROAD SUITE 100 SAN DIEGO CA 92121 858-224-1000
ORGANOVO HOLDINGS, INC. (Filer) CIK: 0001497253 (see all company filings)

EIN.: 271488943 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-35996 | Film No.: 25637595
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)